Due to its enhanced stability compared to native GLP-1, Semaglutide allows for the study of prolonged receptor engagement and modulation of downstream pathways
Common side effects of Semaglutide include nausea, vomiting, diarrhea, and constipation
Healthcare providers face challenges including patient eligibility assessment, insurance coverage complexities, dosage titration management, side effect monitoring, and cost considerations when prescribing Semaglutide
Other Serious Side Effects Can Include: Pancreatitis (inflamed pancreas) Cholelithiasis (gallbladder disease) Kidney damage Low blood sugar (hypoglycemia) Allergic reactions (including swelling of the face, tongue, or throat
The numbers are small, but a few recent studies show a possible connection